Hub Services Comparison

AI Prior Authorization Vendors: Infinitus vs SuperDial vs Neon Health vs Coral AI

Head-to-head comparison of four AI-native prior authorization automation vendors targeting different segments of the pharma patient access workflow. Represents the emerging question of where AI inserts into the PA process: voice-based payer call automation (Infinitus, SuperDial), end-to-end multi-channel workflow orchestration (Neon Health), or pre-submission document AI (Coral AI).

Rx Almanac Research Published April 9, 2026 Updated June 1, 2026 10 min read 2 vendors

Curated by Rx Almanac using company materials, public reporting, and editorial synthesis.

On this page

Ranked Vendors

Top 2

Infinitus Systems Proven high-scale AI payer call automation (8 of top 10 pharma)

Voice AI platform for payer phone workflows, benefit verification, prior authorization follow-up, and healthcare access operations.

View full profile →

Neon Health End-to-end hub workflow automation (BV through PA to financial assistance)

AI-native patient access automation layer for specialty-drug hub workflows, payer calls, benefit verification, prior authorization, and affordability operations.

View full profile →

Save this comparison — email yourself the full breakdown.

Join 200+ biotech launch teams on the weekly digest.

Overview

Prior authorization is one of the most expensive administrative burdens in U.S. healthcare. A Health Affairs analysis estimated that drug utilization management costs payers, manufacturers, physicians, and patients approximately $93.3 billion annually.

Regulatory tailwinds are compounding demand: the CMS Interoperability and Prior Authorization Final Rule sets compliance deadlines mandating electronic PA APIs with 72-hour urgent and 7-day standard turnaround times. Pharmacy-benefit PA, commercial-plan workflows, payer calls, faxes, portals, and exception handling still leave room for AI automation outside the CMS mandate.

Within this landscape, four vendors have emerged as distinctive competitors in the AI-native PA automation space: Infinitus Systems, SuperDial, Neon Health, and Coral AI. They reflect fundamentally different architectural bets, market hypotheses, and customer profiles.

For buyers evaluating AI within a broader hub or patient-support stack, incumbent access platforms like AssistRx, ConnectiveRx, and EVERSANA remain the baseline alternatives or integration environments these AI tools must augment, replace, or outperform.

Two adjacent specialists sit just outside the core four-way comparison and deserve buyer awareness: 100ms, a voice-first workflow entrant oriented toward intake, benefits, and specialty-pharmacy-style access operations; and RISA Labs, an oncology-only operating system for authorization, denial, and status-tracking workflows. Neither is yet broad enough to displace the four archetypes above as default comparators, but both are credible shortlist adds in the right use case.

Competitor Profiles

Infinitus Systems

Founded in 2019, headquartered in San Francisco. Built an AI platform designed to automate manual healthcare phone calls. For pharma, Infinitus focuses on call-intensive hub workflows: benefit verification, PA follow-up, PBM discovery, and formulary exception requests. The company announced a $51.5 million Series C in October 2024 and publicly framed its cumulative funding as above $100 million (PR Newswire).

SuperDial

Founded late 2023, headquartered in San Francisco. Builds AI agents that make outbound phone calls from providers and billing companies to insurers. Raised a $15 million Series A in June 2025 led by SignalFire, bringing total funding above $20 million; it also acquired voice AI specialist MajorBoost for call-tree navigation (FierceHealthcare). Customer base is primarily RCM companies, dental service organizations, and large provider organizations — not pharma manufacturers or hub services.

Neon Health

Founded in San Francisco, raised a $6 million seed round in September 2025 led by NFX (Endpoints News). Positioning is explicitly around specialty drug access for pharma manufacturers. CareMetx is the main public design-partner reference. Differentiation is multi-channel, end-to-end workflow orchestration purpose-built for the specialty Rx journey.

Coral AI

Founded in New York in 2024. Attacks the front-end of the patient access workflow: document intake, eligibility verification, and PA preparation. Seed round led by Lightspeed Venture Partners with participation from leaders at OpenAI and Zapier. Custom-trained models on real healthcare documents capable of reading handwriting, flipped insurance cards, and unstructured text. Coral says it processes over 500,000 patient workflows per month across DME providers, infusion centers, and specialty clinics (PR Newswire); customer base is provider-side, not pharma.

Head-to-Head Comparison

Comparison framing note: SuperDial is included for adjacency context — its primary customer base is RCM companies, dental service organizations, and provider billing teams, NOT pharma manufacturers or hub services. Pharma buyers should treat SuperDial as a watchlist vendor (interesting voice-AI tech) rather than a viable PA-automation choice for hub workflows. The matrix below preserves SuperDial for technology comparison; the prose later in this page elaborates the pharma-fit caveat.

At a Glance

Dimension	Infinitus	SuperDial (RCM/providers — not pharma)	Neon Health	Coral AI
Founded	2019	2023	2024	2024
Total Funding	$100M+ publicly reported	$20M+	$6M	Seed (Lightspeed)
Stage	Series C	Series A	Seed	Seed
Primary tech	Voice AI (payer calls)	Voice AI (payer calls)	Multi-channel AI workers	Document AI + agentic workflows
Primary customer	Pharma / Hub services	RCM / Providers	Pharma / Hub services	Providers (DME, infusion, clinic)
PA workflow stage	Post-submission follow-up	Post-submission follow-up	End-to-end (BV through PA through fin. assist.)	Pre-submission (intake, prep, drafting)

Technology Architecture

Dimension	Infinitus	SuperDial	Neon Health	Coral AI
Core approach	Proprietary multimodal AI platform with discrete action space and knowledge graph	Voice AI agents + human call center fallback	Modular AI workforce: voice, web portal, SMS/fax/email, rules engine	Document AI (CV + ML) for unstructured data; agentic workflow automation
Hallucination control	Discrete action space limits LLM to approved response set; guardrails at every layer	Human-in-the-loop escalation	Rules Engine with company-reported 100% SOP scoring; human-in-the-loop exceptions	Custom-trained models on real docs; humans review/submit; company-reported 98.7% accuracy (Forbes)
Payer interaction	Voice AI calls payer, navigates IVR, multi-turn conversation	Voice AI calls payer, navigates IVR, talks to rep	Voice + portal navigation + fax (multi-channel)	Primarily portal/document-based
Key claim	Mature payer-call automation	Provider-side call automation	End-to-end specialty-access workflow automation	Document intake and PA-prep automation
Compliance	HIPAA, SOC 2 Type 2, HITRUST Certified Cloud	HIPAA, SOC 2 Type 2	HIPAA compliant	HIPAA, payer compliance

Maturity and Scale

Dimension	Infinitus	SuperDial	Neon Health	Coral AI
Years in market	~6	~2	~1	~1
Volume	Publicly reported large payer-call footprint	Not independently benchmarked here	Not disclosed	Publicly reported document-workflow growth
Payer coverage	Broad payer-call coverage	Not specified	Not specified	Not primarily payer-call-based
Pharma customers	Public pharma / hub references exist	Not disclosed (primarily providers, RCM)	Emerging pharma / hub references	Not disclosed
Hub services customers	Yes (Amgen SupportPlus, multiple hub partners)	No known hub relationships	CareMetx (design partner / reference)	No known hub relationships

Integration Model

Dimension	Infinitus	SuperDial	Neon Health	Coral AI
Hub/PSP role	Augments hub — automates payer call tasks	Not designed for hub services	Augments hub — purpose-built to embed in hub workflows	Does not target hub services
Deployment	API or Infinitus Portal; FastTrack copilot starts without integration	API integration with EHR/RCM	API and CRM/case management integration	EHR integration; adapts to existing workflows
Time to value	FastTrack copilot starts without integration; full API weeks	Relatively fast	Custom build (weeks to months)	Day 1 value

Pricing (Inferred)

Vendor	Pricing Model	Notes
Infinitus	Per-call / per-task, enterprise contracts	Validate ROI claim against comparable hub workflow
SuperDial	Per-call pricing	Company-reported cost savings vs. manual calls; validate against the target workflow
Neon Health	Custom / outcome-based per workflow	Validate case-study metrics in RFP diligence
Coral AI	Per-workflow or subscription	Growth metrics suggest volume-based pricing

Use Case Recommendations

When to choose Infinitus

Default choice for mid-to-large pharma manufacturers and hub services organizations needing high-volume payer call automation at proven enterprise scale. Funding, customer references, and a mature payer-call architecture make it the most battle-tested option in this set.

Best for:

Hub services operations managing BV and PA follow-up calls for specialty medications
Proven performance at scale across hundreds of payers
Post-submission PA follow-up tracking automation
FastTrack copilot mode for IVR bypass without full integration
Maximum compliance/hallucination control requirements

Weakness: Not a pre-submission or PA initiation tool. Voice-first — lacks portal automation or multi-channel orchestration.

When to choose Neon Health

Strongest choice for hub services organizations wanting end-to-end workflow automation across the full specialty Rx journey. The CareMetx design-partner relationship is the key public proof point, but exact performance metrics should be validated before use in an ROI model.

Best for:

Hub programs with high BV and PA call volume
Extending beyond payer calls to patient onboarding, copay enrollment, adherence
Multi-channel hubs (portal, phone, fax, SMS) wanting single automation layer
Custom workflow requirements

Weakness: Seed stage with six pharma brand customers and $6M raised per the September 2025 funding announcement. Custom-build model means slower time to value versus Infinitus.

When to choose SuperDial

Not purpose-built for pharma manufacturer or hub services workflows. Customers are RCM companies, DSOs, and provider billing teams. Not the right fit for pharma commercial operations evaluating AI PA for hub or PSP.

Relevant for: specialty pharmacies, infusion centers, or physician practices managing PA calls in-house. Could be a tool for a specialty pharmacy in a manufacturer’s preferred network.

When to choose Coral AI

Not a PA automation vendor in the pharma hub services sense. Value is in pre-submission: reading messy referral packets, extracting data, checking eligibility, drafting PA requests. Customers are DME providers, infusion centers, specialty clinics.

Relevant to pharma if: building or operating a hub that handles inbound referral documents from providers. Could layer in before handing off to a voice AI tool like Infinitus or Neon Health.

Specialist watchlist outside the core four

100ms is worth screening when the buyer needs a voice-led layer that spans patient intake, benefits verification, scheduling, and PA-adjacent conversations rather than a pure post-submission follow-up tool. The product posture is closer to “AI operations fabric for specialty access workflows” than to a single PA point solution. It is most relevant for specialty pharmacies, AI-forward provider groups, and hubs looking to automate phone-heavy work without fully re-platforming.

RISA Labs belongs on oncology-specific shortlists when the real bottleneck is not generic PA volume but cancer-service-line complexity: multi-drug regimens, buy-and-bill vs. pharmacy-benefit routing, denials, and highly variable payer policy. It is more specialized than Neon or Infinitus and less generalizable across therapy areas, but that specialization is precisely the point for oncology-heavy buyers.

Verdict

Vendor Strength/Weakness Summary

Vendor	Strongest At	Weakest At
Infinitus	Payer call automation at scale; pharma/hub use cases; compliance; broad payer-call coverage	Pre-submission PA prep; multi-channel orchestration beyond voice
SuperDial	Provider-side RCM call automation; cost-per-call economics	Pharma/hub services fit; specialty therapy knowledge
Neon Health	End-to-end patient access workflows; hub services fit; multi-channel; CareMetx reference	Early stage; limited scale data; custom-build model slows deployment
Coral AI	Pre-submission document intake and PA preparation; unstructured document handling	Payer call automation; pharma/hub fit; specialty therapy depth

Overall Recommendation for Pharma Commercial Operations

Go with Infinitus if you need proven enterprise-scale payer call automation today. The payer-call workflow depth and compliance architecture maturity are the main reasons it leads this specific use case.

Shortlist Neon Health as a strategic alternative or complement — particularly for end-to-end hub workflow automation beyond payer calls. The CareMetx partnership signals strong product-market fit. Accept early-customer risk and negotiate accordingly.

Avoid SuperDial and Coral AI for pharma hub services PA workflows — not because they are weak products, but because they are built for different buyers. Both could become relevant as point solutions (Coral for document intake; SuperDial for SP-side RCM).

The competitive picture will shift as Neon Health scales. If it raises a meaningful Series A, it will be a genuine challenger to Infinitus for new hub program mandates.

Editorial Firewall Disclosure

This comparison is written by the Rx Almanac editorial team using publicly available sources. None of the vendors named (Infinitus Systems, SuperDial, Neon Health, Coral AI) has sponsored, reviewed, or approved this content. Material public claims are cited inline where they need immediate context. Feedback and correction requests via the contact page; fact-based corrections are applied on verification, promotional edits are not accepted.

Vendor Profiles

Infinitus Systems
SuperDial
Neon Health
Coral AI
100ms
RISA Labs
CareMetx — Neon Health design partner/reference customer

Category Pages

Concept Pages

Prior Authorization
Hub Services Overview
Patient Access Journey

Rx Almanac maintains a private source register for each article. Material public claims are cited inline; sourcing standards and correction policy are described in our methodology.

Frequently Asked Questions

What are the best AI prior authorization tools for pharma?

For pharma manufacturers and hub services, Infinitus Systems is the more mature voice-AI payer-call automation option, while Neon Health is the emerging end-to-end hub-workflow automation alternative. SuperDial and Coral AI serve provider-side and RCM use cases rather than pharma hub services.

How much can AI reduce prior authorization costs?

AI PA automation can reduce manual payer-call, document-intake, and status-follow-up work, but vendor-published ROI claims should be validated against comparable workflows before being used in a business case. Total drug utilization-management costs are estimated at $93.3 billion per year across the system.

What is the CMS prior authorization rule and how does it affect pharma?

The CMS Interoperability and Prior Authorization Final Rule sets compliance deadlines mandating electronic PA APIs with 72-hour urgent and 7-day standard turnaround times. This regulatory tailwind is accelerating buyer diligence around AI PA tools, but pharmacy-benefit PA, commercial plans, and exception workflows still require workflow automation outside the CMS mandate.

Should pharma companies use Infinitus or Neon Health for AI prior authorization?

Infinitus is the safer choice for enterprises needing proven, high-scale payer call automation today, with 6 years in market, HITRUST certification, and deep payer coverage. Neon Health is the stronger choice for hub organizations wanting end-to-end workflow automation beyond just payer calls, covering BV through PA through financial assistance across voice, portal, fax, and SMS channels. Many programs may benefit from both: Neon Health for multi-channel orchestration and Infinitus for high-volume voice automation at scale.

Analysis

AI Disruption in Pharma Services: Market Structure Implications

AI will change pharma services economics first by compressing routine administrative labor, not by replacing the full hub, specialty-pharmacy, or patient-services operating model. The strongest current use cases are high-volume PA, BV, document intake, payer-status calls, and workflow triage; the weakest are clinical counseling, rare-disease judgment, CGT coordination, and accountable patient support.

Guide

Field Reimbursement Managers (FRMs): What They Do, Cost, and How to Deploy

Operator guide to FRM programs: functions, loaded-cost modeling, territory sizing, deployment vendors, hub integration, and ROI measurement for specialty launches.